Airain Ltd’s Medicines Co MDCO Stock Holding History

Airain Ltd’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-24,888	Closed	-$723K	–	1057
2014 Q2	$723K	Buy	+24,888	New	+$665K	0.06%	335

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Airain Ltd's MDCO Position: Q3 2014 in Review

Airain Ltd sold out of Medicines Co (MDCO) in Q3 2014, closing a stake of 24,888 shares — an estimated $723K sold.

Airain Ltd first reported a position in MDCO in Q2 2014 and held it in 1 quarter. The position peaked at $723K in Q2 2014. 152 funds tracked by Wall St. Rank hold MDCO as of Q3 2014.

Airain Ltd reported no remaining Medicines Co position as of Q3 2014 after selling out during the quarter.
Airain Ltd sold 24,888 Medicines Co shares in Q3 2014, an estimated $723K.
Airain Ltd first reported a position in Medicines Co in Q2 2014 and held it in 1 quarter.
Airain Ltd's Medicines Co position peaked at $723K in Q2 2014.
152 funds tracked by Wall St. Rank held Medicines Co as of Q3 2014.

Based on Airain Ltd's 13F filing for Q3 2014, filed 7 Nov 2014.